IntegraGen SA (EPA:ALINT)
France · Delayed Price · Currency is EUR 0.2010
+0.0150 (8.06%)
Aug 3, 2026, 12:06 PM CET
IntegraGen Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.12 | 0.85 | 2.88 | 4.51 | 4.78 |
Short-Term Investments | - | 1.05 | - | - | - |
Cash & Short-Term Investments | 1.12 | 1.9 | 2.88 | 4.51 | 4.78 |
Cash Growth | -41.32% | -33.98% | -36.13% | -5.73% | -6.71% |
Accounts Receivable | 1 | 1.67 | 2.96 | 3.22 | 3.36 |
Other Receivables | 0.26 | 1.31 | 1.34 | 0.27 | 0.31 |
Total Trade Receivables | 1.26 | 2.98 | 4.3 | 3.49 | 3.67 |
Inventory | 0.13 | 0.2 | 0.31 | 0.39 | 0.34 |
Other Current Assets | 0.15 | 0.18 | 0.19 | 0.17 | 0.18 |
Total Current Assets | 2.65 | 5.26 | 7.68 | 8.56 | 8.97 |
Net Property, Plant & Equipment | 0.14 | 0.23 | 0.29 | 0.55 | 0.83 |
Long-Term Investments | 0.17 | 0.27 | 0.35 | 0.38 | 0.42 |
Other Long-Term Assets | - | 0 | - | - | 0.01 |
Total Assets | 2.81 | 5.52 | 8 | 9.02 | 9.6 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.15 | 0.91 | 1.32 | 1.61 | 1.77 |
Accrued Expenses | 1.06 | 1.03 | 1.6 | 1.61 | 1.78 |
Short-Term Debt | 0.61 | 1.29 | 2.25 | 3.34 | 3.91 |
Unearned Revenue | 0.84 | 1.13 | 1.76 | 1.91 | 1.64 |
Other Current Liabilities | 0.01 | 0.03 | 0.03 | 0.05 | 0.26 |
Total Current Liabilities | 3.36 | 3.75 | 2.94 | 3.24 | 3.82 |
Other Long-Term Liabilities | 0.71 | 0.02 | 0.31 | - | 0.02 |
Total Long-Term Liabilities | 0.71 | 0.02 | 0.31 | - | 0.02 |
Total Liabilities | 4.07 | 3.77 | 3.25 | 3.24 | 3.83 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 3.36 | 3.36 | 3.36 | 3.36 | 3.36 |
Retained Earnings | -4.27 | -1.61 | -1.35 | -1.18 | -1.18 |
Shareholders' Equity | -0.91 | 1.76 | 2.01 | 2.18 | 2.19 |
Total Liabilities & Equity | 2.81 | 5.52 | 8 | 9.02 | 9.6 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.61 | 1.29 | 2.25 | 3.34 | 3.91 |
Net Cash (Debt) | 0.51 | 0.61 | 0.63 | 1.16 | 0.88 |
Net Cash Growth | -17.69% | -2.29% | -45.89% | 32.87% | -19.97% |
Net Cash Per Share | 0.07 | 0.09 | 0.09 | 0.33 | 0.11 |
Book Value | -0.91 | 1.76 | 2.01 | 2.18 | 2.19 |
Book Value Per Share | -0.14 | 0.26 | 0.29 | 0.62 | 0.28 |
Tangible Book Value | -0.91 | 1.76 | 2.01 | 2.18 | 2.19 |
Tangible Book Value Per Share | -0.14 | 0.26 | 0.29 | 0.62 | 0.28 |